These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 21717822)

  • 1. Policosanol for managing human immunodeficiency virus-related dyslipidemia in a medically underserved population: a randomized, controlled clinical trial.
    Swanson B; Keithley JK; Sha BE; Fogg L; Nerad J; Novak RM; Adeyemi O; Spear GT
    Altern Ther Health Med; 2011; 17(2):30-5. PubMed ID: 21717822
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Policosanol is ineffective in the treatment of hypercholesterolemia: a randomized controlled trial.
    Dulin MF; Hatcher LF; Sasser HC; Barringer TA
    Am J Clin Nutr; 2006 Dec; 84(6):1543-8. PubMed ID: 17158441
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of policosanol on lipid levels among patients with hypercholesterolemia or combined hyperlipidemia: a randomized controlled trial.
    Berthold HK; Unverdorben S; Degenhardt R; Bulitta M; Gouni-Berthold I
    JAMA; 2006 May; 295(19):2262-9. PubMed ID: 16705107
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of policosanol 20 versus 40 mg/day in the treatment of patients with type II hypercholesterolemia: a 6-month double-blind study.
    Castaño G; Mas R; Fernández L; Illnait J; Gámez R; Alvarez E
    Int J Clin Pharmacol Res; 2001; 21(1):43-57. PubMed ID: 11708574
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evolocumab in HIV-Infected Patients With Dyslipidemia: Primary Results of the Randomized, Double-Blind BEIJERINCK Study.
    Boccara F; Kumar PN; Caramelli B; Calmy A; López JAG; Bray S; Cyrille M; Rosenson RS;
    J Am Coll Cardiol; 2020 May; 75(20):2570-2584. PubMed ID: 32234462
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of addition of policosanol to omega-3 fatty acid therapy on the lipid profile of patients with type II hypercholesterolaemia.
    Castaño G; Fernández L; Mas R; Illnait J; Gámez R; Mendoza S; Mesa M; Fernández J
    Drugs R D; 2005; 6(4):207-19. PubMed ID: 16050054
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of sugar cane policosanol on lipid profile in primary hypercholesterolemia.
    Francini-Pesenti F; Beltramolli D; Dall'acqua S; Brocadello F
    Phytother Res; 2008 Mar; 22(3):318-22. PubMed ID: 18167048
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of sugarcane policosanol on dyslipidemia: A meta-analysis of randomized controlled trials.
    Gong J; Qin X; Yuan F; Hu M; Chen G; Fang K; Wang D; Jiang S; Li J; Zhao Y; Huang Z; Dong H; Lu F
    Mol Nutr Food Res; 2018 Jan; 62(1):. PubMed ID: 28730734
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative lipid-lowering effects of policosanol and atorvastatin: a randomized, parallel, double-blind, placebo-controlled trial.
    Cubeddu LX; Cubeddu RJ; Heimowitz T; Restrepo B; Lamas GA; Weinberg GB
    Am Heart J; 2006 Nov; 152(5):982.e1-5. PubMed ID: 17070175
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and tolerability of policosanol in hypercholesterolemic postmenopausal women.
    Mirkin A; Mas R; Martinto M; Boccanera R; Robertis A; Poudes R; Fuster A; Lastreto E; Yañez M; Irico G; McCook B; Farré A
    Int J Clin Pharmacol Res; 2001; 21(1):31-41. PubMed ID: 11708573
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and Safety of Policosanol Plus Fenofibrate Combination Therapy in Elderly Patients with Mixed Dyslipidemia: A Randomized, Controlled Clinical Study.
    Wang HY; Jiao QP; Chen SY; Sheng J; Jiang H; Lu J; Zheng SB; Fang NY
    Am J Med Sci; 2018 Sep; 356(3):254-261. PubMed ID: 30286820
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of policosanol on postmenopausal women with type II hypercholesterolemia.
    Castaño G; Más R; Fernández L; Fernández JC; Illnait J; López LE; Alvarez E
    Gynecol Endocrinol; 2000 Jun; 14(3):187-95. PubMed ID: 10923280
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pitavastatin versus pravastatin in adults with HIV-1 infection and dyslipidaemia (INTREPID): 12 week and 52 week results of a phase 4, multicentre, randomised, double-blind, superiority trial.
    Aberg JA; Sponseller CA; Ward DJ; Kryzhanovski VA; Campbell SE; Thompson MA
    Lancet HIV; 2017 Jul; 4(7):e284-e294. PubMed ID: 28416195
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of policosanol and lovastatin on lipid profile and lipid peroxidation in patients with dyslipidemia associated with type 2 diabetes mellitus.
    Castaño G; Menéndez R; Más R; Amor A; Fernández JL; González RL; Lezcay M; Alvarez E
    Int J Clin Pharmacol Res; 2002; 22(3-4):89-99. PubMed ID: 12837046
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of hypercholesterolemia in NIDDM with policosanol.
    Torres O; Agramonte AJ; Illnait J; Más Ferreiro R; Fernández L; Fernández JC
    Diabetes Care; 1995 Mar; 18(3):393-7. PubMed ID: 7555484
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of a policosanol supplement on serum lipid concentrations in hypercholesterolaemic and heterozygous familial hypercholesterolaemic subjects.
    Greyling A; De Witt C; Oosthuizen W; Jerling JC
    Br J Nutr; 2006 May; 95(5):968-75. PubMed ID: 16611388
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Short-term ezetimibe is well tolerated and effective in combination with statin therapy to treat elevated LDL cholesterol in HIV-infected patients.
    Chow D; Chen H; Glesby MJ; Busti A; Souza S; Andersen J; Kohrs S; Wu J; Koletar SL
    AIDS; 2009 Oct; 23(16):2133-41. PubMed ID: 19770624
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Concomitant use of policosanol and beta-blockers in older patients.
    Castaño G; Mas R; Gámez R; Fernández J; Illnait J; Fernández L; Mendoza S; Mesa M; Gutiérrez JA; López E
    Int J Clin Pharmacol Res; 2004; 24(2-3):65-77. PubMed ID: 15689053
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lack of cholesterol-lowering efficacy of Cuban sugar cane policosanols in hypercholesterolemic persons.
    Kassis AN; Jones PJ
    Am J Clin Nutr; 2006 Nov; 84(5):1003-8. PubMed ID: 17093150
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evolocumab treatment in patients with HIV and hypercholesterolemia/mixed dyslipidemia: BEIJERINCK study design and baseline characteristics.
    Boccara F; Kumar P; Caramelli B; Calmy A; López JAG; Bray S; Cyrille M; Rosenson RS
    Am Heart J; 2020 Feb; 220():203-212. PubMed ID: 31841795
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.